Rapid Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509244073

Publication Date:

September 20, 2024

Pages:

107

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Rapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor鈥檚 office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick blood or saliva.

For people taking a test, the defining feature is that the result can usually be given within 20 or 30 minutes, which is often more convenient and can mean that many more people actually receive their test results.
The global market for Rapid Tests was estimated to be worth US$ 10510 million in 2023 and is forecast to a readjusted size of US$ 14630 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030
Factors such as increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and the need for low-cost diagnostic testing coupled with diagnosis accuracy are expected to boost the growth of the rapid tests market during the forecast period. In addition, growth in personalized care and increase in promotional activities by manufacturers encourage the use of rapid tests, thereby propelling the growth of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapid Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rapid Tests by region & country, by Type, and by Application.
The Rapid Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Tests.
Market Segmentation
By Company
Akers Biosciences, Inc.
Abbott
Becton, Dickinson and Company
Bio-rad Laboratories, Inc.
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Segment by Type:
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
Segment by Application
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rapid Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rapid Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rapid Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Rapid Tests Product Introduction
1.2 Global Rapid Tests Market Size Forecast
1.3 Rapid Tests Market Trends & Drivers
1.3.1 Rapid Tests Industry Trends
1.3.2 Rapid Tests Market Drivers & Opportunity
1.3.3 Rapid Tests Market Challenges
1.3.4 Rapid Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rapid Tests Players Revenue Ranking (2023)
2.2 Global Rapid Tests Revenue by Company (2019-2024)
2.3 Key Companies Rapid Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rapid Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of Rapid Tests
2.6 Rapid Tests Market Competitive Analysis
2.6.1 Rapid Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rapid Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Over-the-counter (OTC) Rapid Test Product
3.1.2 Professional Rapid Test Product
3.2 Global Rapid Tests Sales Value by Type
3.2.1 Global Rapid Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rapid Tests Sales Value, by Type (2019-2030)
3.2.3 Global Rapid Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infectious Disease
4.1.2 Cardiology
4.1.3 Oncology
4.1.4 Pregnancy and Fertility
4.1.5 Toxicology
4.1.6 Glucose Monitoring
4.1.7 Others
4.2 Global Rapid Tests Sales Value by Application
4.2.1 Global Rapid Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rapid Tests Sales Value, by Application (2019-2030)
4.2.3 Global Rapid Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rapid Tests Sales Value by Region
5.1.1 Global Rapid Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rapid Tests Sales Value by Region (2019-2024)
5.1.3 Global Rapid Tests Sales Value by Region (2025-2030)
5.1.4 Global Rapid Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rapid Tests Sales Value, 2019-2030
5.2.2 North America Rapid Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rapid Tests Sales Value, 2019-2030
5.3.2 Europe Rapid Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rapid Tests Sales Value, 2019-2030
5.4.2 Asia Pacific Rapid Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rapid Tests Sales Value, 2019-2030
5.5.2 South America Rapid Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rapid Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa Rapid Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rapid Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rapid Tests Sales Value
6.3 United States
6.3.1 United States Rapid Tests Sales Value, 2019-2030
6.3.2 United States Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rapid Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rapid Tests Sales Value, 2019-2030
6.4.2 Europe Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rapid Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rapid Tests Sales Value, 2019-2030
6.5.2 China Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rapid Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rapid Tests Sales Value, 2019-2030
6.6.2 Japan Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rapid Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rapid Tests Sales Value, 2019-2030
6.7.2 South Korea Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rapid Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rapid Tests Sales Value, 2019-2030
6.8.2 Southeast Asia Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rapid Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rapid Tests Sales Value, 2019-2030
6.9.2 India Rapid Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rapid Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Akers Biosciences, Inc.
7.1.1 Akers Biosciences, Inc. Profile
7.1.2 Akers Biosciences, Inc. Main Business
7.1.3 Akers Biosciences, Inc. Rapid Tests Products, Services and Solutions
7.1.4 Akers Biosciences, Inc. Rapid Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Akers Biosciences, Inc. Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Rapid Tests Products, Services and Solutions
7.2.4 Abbott Rapid Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Profile
7.3.2 Becton, Dickinson and Company Main Business
7.3.3 Becton, Dickinson and Company Rapid Tests Products, Services and Solutions
7.3.4 Becton, Dickinson and Company Rapid Tests Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-rad Laboratories, Inc. Recent Developments
7.4 Bio-rad Laboratories, Inc.
7.4.1 Bio-rad Laboratories, Inc. Profile
7.4.2 Bio-rad Laboratories, Inc. Main Business
7.4.3 Bio-rad Laboratories, Inc. Rapid Tests Products, Services and Solutions
7.4.4 Bio-rad Laboratories, Inc. Rapid Tests Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-rad Laboratories, Inc. Recent Developments
7.5 Cepheid, Inc.
7.5.1 Cepheid, Inc. Profile
7.5.2 Cepheid, Inc. Main Business
7.5.3 Cepheid, Inc. Rapid Tests Products, Services and Solutions
7.5.4 Cepheid, Inc. Rapid Tests Revenue (US$ Million) & (2019-2024)
7.5.5 Cepheid, Inc. Recent Developments
7.6 Hologic, Inc.
7.6.1 Hologic, Inc. Profile
7.6.2 Hologic, Inc. Main Business
7.6.3 Hologic, Inc. Rapid Tests Products, Services and Solutions
7.6.4 Hologic, Inc. Rapid Tests Revenue (US$ Million) & (2019-2024)
7.6.5 Hologic, Inc. Recent Developments
7.7 Meridian Bioscience, Inc.
7.7.1 Meridian Bioscience, Inc. Profile
7.7.2 Meridian Bioscience, Inc. Main Business
7.7.3 Meridian Bioscience, Inc. Rapid Tests Products, Services and Solutions
7.7.4 Meridian Bioscience, Inc. Rapid Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Meridian Bioscience, Inc. Recent Developments
7.8 OraSure Technologies, Inc.
7.8.1 OraSure Technologies, Inc. Profile
7.8.2 OraSure Technologies, Inc. Main Business
7.8.3 OraSure Technologies, Inc. Rapid Tests Products, Services and Solutions
7.8.4 OraSure Technologies, Inc. Rapid Tests Revenue (US$ Million) & (2019-2024)
7.8.5 OraSure Technologies, Inc. Recent Developments
7.9 Quidel Corporation
7.9.1 Quidel Corporation Profile
7.9.2 Quidel Corporation Main Business
7.9.3 Quidel Corporation Rapid Tests Products, Services and Solutions
7.9.4 Quidel Corporation Rapid Tests Revenue (US$ Million) & (2019-2024)
7.9.5 Quidel Corporation Recent Developments
7.10 Roche Diagnostics
7.10.1 Roche Diagnostics Profile
7.10.2 Roche Diagnostics Main Business
7.10.3 Roche Diagnostics Rapid Tests Products, Services and Solutions
7.10.4 Roche Diagnostics Rapid Tests Revenue (US$ Million) & (2019-2024)
7.10.5 Roche Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Rapid Tests Industrial Chain
8.2 Rapid Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rapid Tests Sales Model
8.5.2 Sales Channel
8.5.3 Rapid Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Akers Biosciences, Inc.
Abbott
Becton, Dickinson and Company
Bio-rad Laboratories, Inc.
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂